Stock listing
LS Exchange:A14YWP Surgery Partners, Inc. Aktie
German listing (LS Exchange) of Surgery Partners, Inc. · home listing NASDAQ:SGRY
Follow Surgery Partners, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SGRY
$26.78 USD -0.18 (-0.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SGRY
- Day range
- $26.64 – $26.96 USDNov 20, 2026
- Volume
- 1.11M sharesNov 20, 2026
- Market cap
- $3.50B USDAt the close on Nov 20, 2026 · price × 130.9M shares outstanding
- 52-week range
- $11.41 – $27.23 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $78.52M USDMedian day 2.27M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SGRY · Home | $26.78 USD | -0.18 (-0.7%) | 1,111,621 | $26.65 | $26.96 | $26.64 | $26.96 | Close on Nov 20, 2026 |
| Frankfurt:1SP | €24.20 EUR | 0.00 (0.0%) | — | €24.00 | €24.20 | €24.00 | €24.20 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SGRY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.78 | -0.18 | -0.7% | $26.65 | $26.96 | $26.64 | 1,111,621 | |
| $26.96 | +0.11 | +0.4% | $26.85 | $27.07 | $26.80 | 3,237,982 | |
| $26.85 | +0.06 | +0.2% | $26.68 | $26.89 | $26.68 | 2,034,137 | |
| $26.79 | -0.16 | -0.6% | $26.75 | $26.95 | $26.62 | 1,607,414 | |
| $26.95 | +0.37 | +1.4% | $26.65 | $26.95 | $26.60 | 3,138,835 | |
| $26.58 | -0.08 | -0.3% | $26.68 | $26.81 | $26.56 | 3,466,913 | |
| $26.66 | -0.07 | -0.3% | $26.40 | $26.70 | $26.39 | 2,607,566 | |
| $26.73 | +0.28 | +1.1% | $26.71 | $26.82 | $26.33 | 7,306,324 | |
| $26.45 | +3.25 | +14.0% | $25.81 | $27.23 | $25.77 | 17,048,983 | |
| $23.20 | +0.03 | +0.1% | $23.17 | $23.23 | $23.17 | 2,824,370 | |
| $23.17 | +0.01 | 0.0% | $23.23 | $23.24 | $23.13 | 5,785,470 | |
| $23.16 | +0.03 | +0.1% | $23.20 | $23.27 | $23.14 | 10,927,979 | |
| $23.13 | +0.01 | 0.0% | $23.19 | $23.22 | $23.12 | 2,274,876 | |
| $23.12 | -0.09 | -0.4% | $23.21 | $23.23 | $23.12 | 3,367,555 | |
| $23.21 | 0.00 | 0.0% | $23.24 | $23.25 | $23.19 | 3,513,600 | |
| $23.21 | -0.03 | -0.1% | $23.25 | $23.28 | $23.17 | 3,535,000 | |
| $23.24 | -0.12 | -0.5% | $23.26 | $23.36 | $23.20 | 3,105,500 | |
| $23.36 | +0.11 | +0.5% | $23.20 | $23.37 | $23.13 | 11,199,300 | |
| $23.25 | +7.50 | +47.6% | $23.03 | $23.29 | $22.94 | 58,815,500 | |
| $15.75 | -0.15 | -0.9% | $15.79 | $16.16 | $15.66 | 3,332,400 | |
| $15.90 | +0.50 | +3.2% | $15.52 | $16.00 | $15.35 | 2,906,300 | |
| $15.40 | -0.09 | -0.6% | $15.19 | $15.64 | $15.07 | 2,355,400 | |
| $15.49 | +0.78 | +5.3% | $14.77 | $15.52 | $14.77 | 4,323,200 | |
| $14.71 | +0.10 | +0.7% | $14.57 | $14.89 | $14.49 | 1,306,400 | |
| $14.61 | -0.16 | -1.1% | $14.86 | $14.90 | $14.51 | 966,800 | |
| $14.77 | -0.06 | -0.4% | $15.05 | $15.34 | $14.62 | 2,369,500 | |
| $14.83 | +0.28 | +1.9% | $14.46 | $14.84 | $14.09 | 1,440,100 | |
| $14.55 | +0.31 | +2.2% | $14.35 | $14.77 | $14.26 | 1,137,700 | |
| $14.24 | +0.35 | +2.5% | $13.85 | $14.32 | $13.68 | 1,212,400 | |
| $13.89 | +0.25 | +1.8% | $13.69 | $14.06 | $13.61 | 929,000 | |
| $13.64 | -0.07 | -0.5% | $13.58 | $13.71 | $13.35 | 1,314,900 | |
| $13.71 | +0.30 | +2.2% | $13.36 | $13.97 | $13.34 | 1,685,900 | |
| $13.41 | +0.08 | +0.6% | $13.43 | $13.57 | $13.22 | 892,300 | |
| $13.33 | +0.01 | +0.1% | $13.26 | $13.50 | $13.16 | 1,566,800 | |
| $13.32 | +0.09 | +0.7% | $13.35 | $13.55 | $13.11 | 1,228,100 | |
| $13.23 | -0.64 | -4.6% | $13.81 | $14.28 | $13.14 | 1,874,300 | |
| $13.87 | -0.54 | -3.7% | $14.32 | $14.42 | $13.86 | 1,857,200 | |
| $14.41 | -0.28 | -1.9% | $14.65 | $14.78 | $14.25 | 1,421,000 | |
| $14.69 | +0.29 | +2.0% | $14.18 | $14.71 | $14.14 | 1,103,800 | |
| $14.40 | +0.20 | +1.4% | $14.22 | $14.67 | $14.19 | 1,762,800 | |
| $14.20 | -0.36 | -2.5% | $14.38 | $14.52 | $13.98 | 2,029,400 | |
| $14.56 | -1.24 | -7.8% | $15.72 | $15.84 | $14.43 | 3,723,600 | |
| $15.80 | +2.14 | +15.7% | $13.79 | $15.90 | $13.67 | 8,109,000 | |
| $13.66 | +0.41 | +3.1% | $13.41 | $13.74 | $13.09 | 2,311,500 | |
| $13.25 | -0.10 | -0.7% | $13.12 | $13.49 | $12.97 | 2,763,800 | |
| $13.35 | -0.58 | -4.2% | $14.10 | $14.15 | $13.26 | 3,806,200 | |
| $13.93 | +0.28 | +2.1% | $13.71 | $14.24 | $13.60 | 1,477,100 | |
| $13.65 | -0.39 | -2.8% | $13.97 | $14.16 | $13.56 | 1,911,200 | |
| $14.04 | -0.34 | -2.4% | $14.44 | $14.73 | $14.02 | 2,162,300 | |
| $14.38 | +0.26 | +1.8% | $14.23 | $14.60 | $14.03 | 1,288,000 | |
| $14.12 | 0.00 | 0.0% | $14.10 | $14.18 | $13.72 | 3,275,300 | |
| $14.12 | +0.16 | +1.1% | $13.87 | $14.49 | $13.59 | 1,680,000 | |
| $13.96 | -0.30 | -2.1% | $14.19 | $14.41 | $13.90 | 2,046,100 | |
| $14.26 | +0.09 | +0.6% | $14.17 | $14.51 | $14.06 | 1,106,600 | |
| $14.17 | +0.19 | +1.4% | $14.13 | $14.37 | $13.88 | 1,634,200 | |
| $13.98 | -0.62 | -4.2% | $14.58 | $14.72 | $13.91 | 2,212,900 | |
| $14.60 | +0.71 | +5.1% | $13.89 | $15.08 | $13.78 | 3,962,500 | |
| $13.89 | +0.20 | +1.5% | $13.65 | $13.93 | $13.18 | 3,922,200 | |
| $13.69 | -0.24 | -1.7% | $13.87 | $13.98 | $13.52 | 2,039,000 | |
| $13.93 | -0.11 | -0.8% | $13.90 | $14.10 | $13.68 | 1,371,800 | |
| $14.04 | -0.01 | -0.1% | $14.01 | $14.39 | $14.00 | 3,297,500 | |
| $14.05 | +0.10 | +0.7% | $13.75 | $14.08 | $13.75 | 2,274,300 | |
| $13.95 | -0.57 | -3.9% | $14.55 | $14.80 | $13.92 | 2,148,100 | |
| $14.52 | +0.58 | +4.2% | $14.10 | $14.55 | $13.79 | 3,876,200 | |
| $13.94 | +0.34 | +2.5% | $13.99 | $14.17 | $13.52 | 6,397,900 |
- Ticker
- LS Exchange:A14YWP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- LS Exchange
- Currency
- EUR
What changed lately
Latest news release · Nov 20, 2026
Surgery Partners, Inc. Announces Expiration and Results of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032
Latest earnings call · Aug 10, 2026
Surgery Partners (NASDAQ:SGRY) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 10, 2026
Q2 2026 Earnings Presentation
Earnings · 9 slides
Latest news
Surgery Partners, Inc. Announces Third Quarter 2026 Results
Nov 9, 2026
Closed $26.73 (+1.1%) on Nov 10, 2026
Surgery Partners and HealthSpan Partners Announce Amended Merger Agreement, Following Receipt of Unsolicited Proposal
Nov 9, 2026
Closed $26.45 (+14.0%) on Nov 9, 2026
SGRY Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Surgery Partners to HealthSpan Partners
Nov 4, 2026
Closed $23.16 (+0.1%) on Nov 4, 2026
HealthSpan Partners to Acquire Surgery Partners, Establishing a Leading Outpatient Surgical Care Platform
Oct 26, 2026
Closed $23.25 (+47.6%) on Oct 26, 2026
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health
Sep 18, 2026
Closed $13.25 (-0.7%) on Sep 18, 2026
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
Sep 17, 2026
Closed $13.35 (-4.2%) on Sep 17, 2026
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
Aug 10, 2026
Closed $15.95 (+2.7%) on Aug 10, 2026
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
Jul 24, 2026
Closed $15.73 (+3.4%) on Jul 24, 2026
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
May 5, 2026
Closed $14.26 (+0.4%) on May 5, 2026
Surgery Partners, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 21 in the last 12 months · 98 in all · newest Nov 20, 2026 · oldest 2019
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 10, 2026
- Decks
- 19 decks · latest Aug 10, 2026
Where Surgery Partners, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SGRY · Home listing | NASDAQ | United States | USD |
| LS Exchange:A14YWP · This page | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14YWP | Lang & Schwarz | Germany | EUR |
| gettex:1SP | gettex | Germany | EUR |
| Tradegate:1SP | Tradegate | Germany | EUR |
| BOATS:SGRY | BOATS | United States | USD |
| Frankfurt:1SP | Frankfurt | Germany | EUR |
| Dusseldorf:1SP | Dusseldorf | Germany | EUR |
| Munich:1SP | Munich | Germany | EUR |
| Stuttgart:1SP | Stuttgart | Germany | EUR |
Valuation
EV/sales 1.9× against a median of 2.0×: 5th lowest of 11 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $6.21B USD
- P/E
- Loss
- EV/sales
- 1.9×
- EV/EBITDA
- 11.5×
- Price/book
- 2.1×
- Gross margin
- 21.1%
- Operating margin
- 10.8%
- Net margin
- −2.6%
- Debt to equity
- 1.8×
- Beta vs S&P 500
- 0.94
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Surgery Partners, Inc. · NASDAQ:SGRY | US$3.50B | US$6.21B | n/a | 1.9× | 11.5× | 2.1× | −2.6% | 1.8× | 0.94 |
| Jointown Pharmaceutical Group Co., Ltd. Class A · SSE:600998 | US$3.91B | US$755.9M | 13.3× | 0.0× | n/a | 0.9× | 1.1% | 0.1× | n/a |
| Doximity, Inc. · NYSE:DOCS | US$3.66B | US$2.95B | 26.2× | 4.5× | 15.3× | 3.9× | 21.1% | 0.0× | 0.74 |
| Dr. Lal PathLabs Limited · NSE:LALPATHLAB | US$3.62B | US$3.47B | 57.5× | 10.6× | 36.0× | 12.2× | 19.2% | 0.1× | n/a |
| Krishna Institute of Medical Sciences Limited · NSE:KIMS | US$3.61B | US$3.93B | 157× | 7.9× | 41.0× | 8.5× | 4.6% | 0.9× | n/a |
| Hims & Hers Health, Inc. · NYSE:HIMS | US$3.30B | US$4.15B | n/a | 1.4× | n/a | 9.3× | −6.7% | 4.4× | 2.64 |
| Acadia Healthcare Company, Inc. · NASDAQ:ACHC | US$3.22B | US$5.41B | n/a | 1.6× | 10.1× | 1.6× | −33.1% | 1.2× | 0.82 |
| Privia Health Group, Inc. · NASDAQ:PRVA | US$3.20B | US$2.76B | 92.1× | 1.1× | 43.3× | 3.9× | 1.4% | 0.0× | 0.23 |
| National HealthCare Corporation · AMEX:NHC | US$2.99B | US$3.27B | 26.1× | 2.1× | 16.0× | 2.7× | 7.2% | 0.5× | 0.37 |
| Guardian Pharmacy Services, Inc. · NYSE:GRDN | US$2.97B | US$2.86B | 39.8× | 2.0× | 24.3× | 10.6× | 5.1% | 0.0× | 0.70 |
| Inventurus Knowledge Solutions Limited · NSE:IKS | US$2.97B | US$2.97B | 36.0× | 8.2× | 23.3× | 9.8× | 22.8% | 0.0× | n/a |
| Median of the others | US$3.26B | US$3.12B | 37.9× | 2.0× | 23.8× | 6.2× | 4.9% | 0.1× | 0.72 |
Forecasts
1 strong buy · 6 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.
- Price target
- 22.90 USD · Analysts' mean
- EPS, year to Dec 2026
- 0.29 · 4 analysts
- Revenue, year to Dec 2026
- 3.19B · 6 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Eric Evans | Chief Executive Officer |
| Kristi Jensen | Market CEO (Northeast) and Enterprise Operational Excellence |
| Noah Clevenger | Market CEO (Illinois) and Enterprise Preferred Vascular |
| Dave Doherty | Executive Vice President – Chief Financial Officer |
| Mike Maley | West Division, President |
| Justin Oppenheimer | Executive Vice President – Chief Operating Officer |
| J. Spencer Clark | Senior Vice President – General Counsel |
| Kelly T. Whelan | Senior Vice President – General Counsel |
| Brent Jacobs | Senior Vice President – Acquisitions and Development |
| Cameron Eades | Senior Vice President – Controller |
| Danielle Burkhalter | Executive Vice President – Chief People and Transformation Officer |
| Dawn Castro | Senior Vice President – Chief Revenue Cycle Officer |
| Jackie Wright | Senior Vice President – Chief Procurement Officer |
| Jane Vanderbilt | Senior Vice President – Business Operations |
| Jennifer Baldock | Executive Vice President – Chief Administrative and Development Officer |
| Jon Fredrickson | Senior Vice President – Chief Information Officer |
| Marissa Brittenham | Executive Vice President – Chief Strategy Officer |
| Patrick Brown | Senior Vice President – Market Growth and Business Development |
| Roxanne Womack | Senior Vice President – Chief Compliance Officer |
| Shannon Yarrow | Senior Vice President – Managed Care |
| Sid Soonasra | Senior Vice President - Physician Practice and Anesthesia Operations |
| Steven Cornelison | Senior Vice President – Treasurer |
| Tamala Norris-McJunkins | Senior Vice President – Enterprise Chief Clinical Officer |
| Jeremy Clark | North Division, President |
| Trent Webb | South Division, President |
Board
| Director | Role |
|---|---|
| Lloyd Dean | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Surgery Partners (NASDAQ:SGRY) Q2 2026 Earnings Call | Mon, Aug 10, 2026 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q1 2026 Earnings Call | Tue, May 05, 2026 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q4 2025 Earnings Call | Tue, Mar 03, 2026 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q3 2025 Earnings Call | Mon, Nov 10, 2025 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q2 2025 Earnings Call | Tue, Aug 05, 2025 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q1 2025 Earnings Call | Mon, May 12, 2025 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q4 2024 Earnings Call | Mon, Mar 03, 2025 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q1 2024 Earnings Call | Tue, May 07, 2024 · 8:30 AM ET | Replay |
All 21 calls
| Call | When | Status |
|---|---|---|
| Surgery Partners (NASDAQ:SGRY) Q4 2023 Earnings Call | Mon, Feb 26, 2024 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q3 2023 Earnings Call | Tue, Nov 07, 2023 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q2 2023 Earnings Call | Tue, Aug 01, 2023 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q1 2023 Earnings Call | Mon, May 01, 2023 · 5:00 PM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q4 2022 Earnings Call | Wed, Mar 01, 2023 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q2 2022 Earnings Call | Tue, Aug 02, 2022 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q1 2022 Earnings Call | Tue, May 03, 2022 · 8:30 AM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q4 2021 Earnings Call | Mon, Feb 28, 2022 · 5:00 PM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q3 2021 Earnings Call | Tue, Nov 02, 2021 · 5:00 PM ET | Replay |
| Surgery Partners (NASDAQ:SGRY) Q2 2021 Earnings Call | Wed, Aug 04, 2021 · 8:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 9, 2026 · After close | +1.1% |
| Q2 2026 | Aug 10, 2026 · Before open | +2.7% |
| Q1 2026 | May 5, 2026 · Before open | +0.4% |
| Q4 2025 | Mar 2, 2026 | −10.2% |
| Q3 2025 | Nov 10, 2025 · Before open | −25.4% |
| Q2 2025 | Aug 5, 2025 · Before open | −0.3% |
| Q1 2025 | May 12, 2025 · Before open | +5.0% |
| Q4 2024 | Feb 24, 2025 · Before open | −0.6% |
| Q3 2024 | Nov 12, 2024 · Before open | −5.9% |
| Q2 2024 | Aug 6, 2024 · Before open | +3.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 7, 2024 · Before open | +8.5% |
| Q4 2023 | Feb 26, 2024 · Before open | −8.6% |
| Q3 2023 | Nov 7, 2023 · Before open | +14.0% |
| Q2 2023 | Aug 1, 2023 · Before open | −4.4% |
| Q1 2023 | May 1, 2023 · After close | −5.6% |
| Q4 2022 | Mar 1, 2023 · Before open | +1.6% |
| Q3 2022 | Nov 8, 2022 · Before open | −2.4% |
| Q2 2022 | Aug 2, 2022 · Before open | −7.4% |
| Q1 2022 | May 3, 2022 · Before open | +7.2% |
| Q4 2021 | Feb 28, 2022 · After close | +4.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 9 slides | Aug 10, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 7 slides | May 5, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 8 slides | Mar 3, 2026 |
| 42nd Annual J.P. Morgan Healthcare Conference (January 2024) | Conference | 35 slides | January 2024 |
| 41st Annual J.P. Morgan HealthCare Conference (January 2023) | Conference | 34 slides | January 2023 |
| 40th Annual J.P. Morgan Healthcare Conference (January 2022) | Conference | 42 slides | January 2022 |
| Investor Presentation (August 2021) | Investor deck | 45 slides | August 2021 |
| Debt Investor Presentation (April 2021) | Debt investors | 19 slides | Apr 20, 2021 |
| 39th Annual J.P. Morgan Healthcare Conference (January 2021) | Conference | 50 slides | January 2021 |
| Debt Investor Presentation (July 2020) | Debt investors | 32 slides | Jul 22, 2020 |
All 19 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Debt Investor Presentation (July 2020) | Debt investors | 28 slides | Jul 22, 2020 |
| 38th Annual J.P. Morgan Healthcare Conference (January 2020) | Conference | 31 slides | Jan 13, 2020 |
| Debt Investor Presentation (March 2019) | Debt investors | 24 slides | Mar 25, 2019 |
| Debt Investor Presentation (March 2019) | Debt investors | 24 slides | March 2019 |
| 37th Annual J.P. Morgan Healthcare Conference (January 2019) | Conference | 14 slides | January 2019 |
| Debt Investor Presentation (October 2018) | Debt investors | 21 slides | October 2018 |
| Debt Investor Presentation (May 2017) | Debt investors | 44 slides | May 23, 2017 |
| Debt Investor Presentation (March 2016) | Debt investors | 32 slides | Mar 18, 2016 |
| Debt Investor Presentation (March 2016) | Debt investors | 8 slides | Mar 14, 2016 |
Financings
| Raise | Date |
|---|---|
| 7.250% senior unsecured notes due 2032 (add-on notes) Update: US$425M Use of proceeds: General corporate purposes, including repaying outstanding borrowings under its revolving credit facility | Dec 11, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$19.00 a share on Sep 30, 2015.
- Price
- US$19.00 a share
- Shares offered
- 14,285,000 shares of common stock
- Offering size
- US$271.4 million
- Underwriters' option
- Up to 2,142,750 more shares
- Underwriters
- BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Citigroup, Morgan Stanley, Credit Suisse, Raymond James, RBC Capital Markets, Stifel · In the order on the cover
- Shares delivered
- On or about Oct 6, 2015
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Apr 22, 2015 |
| Filed publicly | Aug 17, 2015 |
| Amended twice | Newest Sep 21, 2015 |
| Shares registered with an exchange | Sep 28, 2015 |
| Declared effective by the SEC | Sep 30, 2015 |
| Final prospectus, with the price | Oct 2, 2015 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 2, 2015 |
| EFFECT · Notice that a registration is effective | Sep 30, 2015 |
| CERTNAS · Nasdaq's certificate of listing | Sep 29, 2015 |
| CORRESP · Letter to the SEC | Sep 29, 2015 |
| CORRESP · Letter to the SEC | Sep 29, 2015 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 28, 2015 |
| CORRESP · Letter to the SEC | Sep 21, 2015 |
| S-1/A · Registration statement, amended | Sep 21, 2015 |
| UPLOAD · Letter from the SEC | Sep 17, 2015 |
| S-1/A · Registration statement, amended | Sep 14, 2015 |
All 20 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Sep 1, 2015 |
| UPLOAD · Letter from the SEC | Aug 27, 2015 |
| S-1 · Registration statement | Aug 17, 2015 |
| DRSLTR · Letter to the SEC with a draft | Aug 3, 2015 |
| DRS/A · Draft registration statement, amended | Aug 3, 2015 |
| UPLOAD · Letter from the SEC | Jul 7, 2015 |
| DRSLTR · Letter to the SEC with a draft | Jun 22, 2015 |
| DRS/A · Draft registration statement, amended | Jun 22, 2015 |
| UPLOAD · Letter from the SEC | May 20, 2015 |
| DRS · Draft registration statement | Apr 22, 2015 |
Open IPO · From the cover of the final prospectus (424B4) filed Oct 2, 2015
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.31B | 3.11B | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B |
| Cost of revenue | 2.54B | 2.37B | 2.10B | 1.96B | 1.73B | 1.48B | 1.41B | 1.36B | 1.01B | 821.2M |
| Gross profit | 765.0M | 745.6M | 647.5M | 574.9M | 491.4M | 379.8M | 423.8M | 410.0M | 327.4M | 324.2M |
| Research and development | 0 | 0 | 0 | |||||||
| Selling, general and administrative | 522.7M | 138.7M | 120.9M | 102.2M | 104.0M | 97.1M | 88.6M | 93.6M | 76.0M | 60.2M |
| Operating income | 389.5M | 348.8M | 328.0M | 345.2M | 302.2M | 183.0M | 235.9M | 77.8M | 158.2M | 196.5M |
| Depreciation and amortization | 176.0M | 152.6M | 118.1M | 114.8M | 98.8M | 94.8M | 76.5M | 67.4M | 51.9M | 39.6M |
| EBITDA | 565.5M | 501.4M | 446.1M | 460.0M | 401.0M | 277.8M | 312.4M | 145.2M | 210.2M | 236.0M |
| Interest expense | 272.6M | 201.7M | 193.0M | 234.9M | 221.0M | 201.8M | 178.9M | 147.0M | 117.7M | 100.6M |
| Income before tax | 116.9M | 147.1M | 135.0M | 110.3M | 81.2M | -18.8M | 54.6M | -69.2M | 82.3M | 92.2M |
| Income tax | 18.0M | 134.6M | -300.0K | 23.3M | 10.5M | -20.1M | 9.50M | 26.4M | 53.5M | 7.09M |
| Net income | -77.9M | -168.1M | -11.9M | -54.6M | -70.9M | -116.1M | -74.8M | -205.7M | -53.0M | 9.45M |
| Earnings per share, basic | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 | -3.19 | -2.29 | -4.96 | -1.08 | 0.20 |
| Earnings per share, diluted | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 | -3.19 | -2.29 | -4.96 | 0.20 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 239.9M | 269.5M | 195.9M | 282.9M | 389.9M | 317.9M | 92.7M | 184.3M | 174.9M | 69.7M |
| Short-term investments | 74.6M | 90.0M | 3.81M | 10.9M | ||||||
| Receivables | 602.2M | 579.1M | 496.4M | 456.3M | 430.2M | 382.2M | 326.9M | 307.6M | 295.6M | 220.6M |
| Inventory | 96.6M | 88.4M | 75.2M | 71.4M | 61.1M | 56.4M | 46.3M | 43.4M | 45.0M | 28.8M |
| Current assets | 1.15B | 1.12B | 895.0M | 921.0M | 946.1M | 801.5M | 525.5M | 588.3M | 563.2M | 362.0M |
| Property, plant and equipment | 1.16B | 953.8M | 854.7M | 821.0M | 426.3M | 398.5M | 204.3M | |||
| Goodwill | 5.19B | 5.07B | 4.33B | 4.14B | 3.91B | 3.47B | 3.40B | 3.38B | 3.35B | 1.56B |
| Total assets | 8.12B | 7.89B | 6.88B | 6.68B | 6.12B | 5.41B | 5.02B | 4.68B | 4.62B | 2.30B |
| Accounts payable | 208.7M | 208.7M | 171.8M | 151.6M | 124.9M | 100.2M | 96.7M | 83.3M | 84.7M | 49.8M |
| Current liabilities | 615.5M | 624.4M | 523.0M | 493.4M | 536.8M | 556.8M | 398.1M | 349.3M | 303.0M | 186.7M |
| Long-term debt | 3.60B | 3.27B | 2.70B | 2.56B | 2.88B | 2.79B | 2.52B | 2.27B | 2.13B | 1.41B |
| Total debt | 3.74B | 3.40B | 2.80B | 2.63B | 2.96B | 2.88B | 2.60B | 2.33B | 2.31B | 1.47B |
| Total liabilities | 4.59B | 4.25B | 3.51B | 3.40B | 3.82B | 3.79B | 3.32B | 4.68B | 4.62B | 2.30B |
| Shareholders' equity | 1.71B | 1.79B | 1.99B | 2.00B | 1.09B | 115.6M | 296.8M | 404.6M | 654.7M | 9.68M |
| Shares outstanding | 129.3M | 127.1M | 126.6M | 126.0M | 89.3M | 50.5M | 49.3M | 48.9M | 49.0M | 48.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 274.3M | 300.1M | 293.8M | 158.8M | 87.1M | 246.9M | 129.5M | 144.6M | 120.9M | 125.2M |
| Capital spending | -78.7M | -90.4M | -88.8M | -80.6M | -57.6M | -42.9M | -73.6M | -39.8M | -29.6M | -39.1M |
| Free cash flow | 195.6M | 209.7M | 205.0M | 78.2M | 29.5M | 204.0M | 55.9M | 104.8M | 91.3M | 86.1M |
| Cash from investing | -246.6M | -488.5M | -225.6M | -307.9M | -331.7M | -88.4M | -85.2M | -128.9M | -783.4M | -184.7M |
| Cash from financing | -57.3M | 262.0M | -155.2M | 42.1M | 316.3M | 66.7M | -135.9M | -6.30M | 767.7M | 71.3M |
| Dividends paid | 0 | -146.8M | -5.10M | -109.6M | -121.2M | -7.80M | -1.32M | -85.9M | ||
| Share buybacks | 854.3M | -233.5M | 0 | 0 | -2.00M | -2.00M | 0 | |||
| Change in cash | -29.6M | 73.6M | -87.0M | -107.0M | 71.7M | 225.2M | -91.6M | 9.40M | 11.8M | 11.8M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| DEFA14A · Additional proxy material | Nov 18, 2026 | Meeting notice | SEC |
| 8-K · Current report | Nov 18, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Nov 16, 2026 | Meeting notice | SEC |
| 8-K · Current report | Nov 16, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Nov 9, 2026 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Nov 9, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 9, 2026 | Meeting notice | SEC |
| 8-K · Current report | Nov 9, 2026 | Results | SEC |
| DEFA14A · Additional proxy material | Nov 9, 2026 | Meeting notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 9, 2026 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 6, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Oct 28, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 27, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 26, 2026 | Meeting notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Oct 26, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Oct 26, 2026 | Meeting notice | SEC |
| 8-K · Current report | Oct 26, 2026 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 13, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Sep 17, 2026 | Acquisition or disposal | SEC |
| 4/A · Change in ownership, amended | Aug 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 10, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 10, 2026 | Results | SEC |
| 8-K · Current report | Jul 24, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jul 14, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 5, 2026 | Meeting outcome | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 6, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| DEFA14A · Additional proxy material | Apr 23, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 23, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 23, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 13, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 13, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 12, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 12, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 9, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 5, 2026 | Other filings | SEC |
| 10-K · Annual report | Mar 2, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 2, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 5, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 16, 2025 | Material contract | SEC |
| 8-K · Current report | Dec 11, 2025 | Current report | SEC |
| 8-K · Current report | Dec 11, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Nov 12, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 10, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2025 | Results | SEC |
| 144 · Notice of proposed sale | Oct 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 23, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 22, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 21, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 16, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 15, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 14, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 9, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 8, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 29, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 26, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 23, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 22, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 17, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 16, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 16, 2025 | Management or board change | SEC |
| 144 · Notice of proposed sale | Sep 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 11, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 8, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 5, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 4, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 4, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 27, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 26, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2025 | Other filings | SEC |
| 4/A · Change in ownership, amended | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Aug 13, 2025 | Material contract | SEC |
| 4 · Change in ownership | Aug 13, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 12, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 8, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 7, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 6, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2025 | Results | SEC |
| CORRESP · Letter to the SEC | Jul 17, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 10, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 8, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 7, 2025 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Jun 26, 2025 | Other filings | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 17, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jun 17, 2025 | Current report | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jun 10, 2025 | Offer document | SEC |
| 8-K · Current report | Jun 6, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 12, 2025 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | May 12, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 12, 2025 | Big-stake notice | SEC |
| 8-K · Current report | May 12, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 29, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 24, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 24, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 24, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 14, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 14, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 14, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 10, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 10, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 10, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 10, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 10, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 10, 2025 | Other filings | SEC |
| 10-K · Annual report | Mar 6, 2025 | Annual report | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| NT 10-K · Late filing notice | Mar 4, 2025 | Explanation request | SEC |
| 8-K · Current report | Mar 3, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 12, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 10, 2025 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Feb 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 7, 2025 | Other filings | SEC |
| 4 · Change in ownership | Feb 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2025 | Insider trade | SEC |
This page holds 200 of 859 filings. Open Filings
Cap table
Built by 6ix from Surgery Partners, Inc.’s releases · as of Nov 2, 2026
- Common shares
- 130,881,223
- Fully diluted
- 130,881,223
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 130,881,223 | Nov 2, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 2, 2026 | 130,881,223 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lloyd Dean Other companies: Progyny, Inc. (Director · Since at least Aug 30, 2022); McDonald's Corporation (Director · Since at least Sep 30, 2017); Bolt Projects Holdings, Inc. (Director · Aug 13, 2024 – Aug 13, 2024 · Past); Golden Arrow Merger Corp (Director · Mar 16, 2021 – Mar 16, 2021 · Past); Wells Fargo & Company (Director · Oct 1, 2017 – Apr 1, 2018 · Past) | Director · Since at least Feb 26, 2026 |
| Wayne S. DeVeydt Other companies: UnitedHealth Group Incorporated (Chief Financial Officer · Since at least Jul 31, 2025); Centene Corporation (Director · Since at least Jan 5, 2022); Myovant Sciences Ltd (Director · Oct 26, 2016 – Aug 18, 2017 · Past); NiSource Inc (Director · Mar 22, 2016 – May 25, 2021 · Past); Elevance Health, Inc. (EVP & Chief Financial Officer · Mar 1, 2006 – Mar 3, 2016 · Past) | Exec Chairman of the Board, Director · Jan 4, 2018 – Mar 21, 2025 · Past |
| Adam T Feinstein Other companies: AirSculpt Technologies, Inc. (Director · Since at least Oct 28, 2021); Quorum Health Corporation (Director · Apr 19, 2016 – Apr 28, 2017 · Past) | Director · Sep 30, 2015 – May 20, 2019 · Past |
| Patricia Anne Maryland Other companies: Encompass Health Corporation (Director · Since at least Jan 1, 2020); Privia Health Group, Inc. (Director · Apr 28, 2021 – May 21, 2025 · Past) | Director · Since at least Mar 10, 2021 |
| Teresa DeLuca Other companies: LifeStance Health Group, Inc. (Director · Since at least Mar 12, 2024); Forum Markets, Incorporated (Director · Jul 9, 2021 – Sep 4, 2023 · Past) | Director · Since at least Sep 30, 2016 |
| Andrew Kaplan Other companies: Kailera Therapeutics, Inc. (Partner, Bain Capital Private Equity · Since at least Apr 16, 2026) | Director · Aug 31, 2018 – Dec 19, 2023 · Past |
| Blair E Hendrix Other companies: iHeartMedia, Inc. (Director · May 1, 2019 – May 1, 2019 · Past) | Director · Since at least Nov 23, 2022 |
| Devin O'Reilly Other companies: Aveanna Healthcare Holdings Inc. (Compensation Committee Chair · Since at least Apr 28, 2021) | Director · May 17, 2021 – Dec 19, 2023 · Past |
| Jason Eric Evans Other companies: Teladoc Health, Inc. (Director · Since at least Sep 20, 2023) | Chief Executive Officer · Since at least Feb 24, 2021 |
| Laura L. Forese Other companies: Cantel Medical Corp (Director · Mar 19, 2015 – Jun 2, 2021 · Past) | Director · Since at least Jan 10, 2025 |
All 51 people
| Person | Seat |
|---|---|
| Sarath Degala Other companies: Privia Health Group, Inc. (Chief Operating Officer · Since at least Nov 4, 2026) | Chief Development Officer · May 23, 2016 – Oct 3, 2016 · Past |
| Thomas F Cowhey Other companies: CVS Health Corporation (EVP and CFO · Oct 13, 2023 – Apr 1, 2025 · Past) | Chief Financial Officer · Apr 2, 2018 – May 6, 2021 · Past |
| Anthony Taparo | Chief Growth Officer · Apr 19, 2018 – Mar 11, 2024 · Past |
| Benjamin F Jacobs | CDO, Grp Pres of SP · Aug 31, 2017 – Aug 31, 2017 · Past |
| Bradley R Owens | National Group President · Jan 1, 2021 – May 31, 2024 · Past |
| Brandan Lingle | Pres., Ancillary Svces. Grp. · Apr 19, 2018 – Mar 31, 2019 · Past |
| Brent Jacobs | Senior Vice President – Acquisitions and Development · Since at least Nov 4, 2026 |
| Brent Turner | Director · Since at least Jun 10, 2025 |
| Bryan S Fisher | EVP, COO of SP Ntl Grp · Aug 31, 2017 – Aug 31, 2018 · Past |
| Cameron Eades | Senior Vice President – Controller · Since at least Nov 4, 2026 |
| Carollee Brinkman | President, National Group · Mar 15, 2019 – Mar 15, 2019 · Past |
| Christopher Laitala | Director · Sep 30, 2015 – Apr 20, 2016 · Past |
| Clifford G Adlerz | Director · Since at least Sep 7, 2017 |
| Danielle Burkhalter | Executive Vice President – Chief People and Transformation Officer · Since at least Jan 19, 2023 |
| Dave Doherty | Executive Vice President – Chief Financial Officer · Since at least Aug 10, 2026 |
| David T Doherty | Chief Financial Officer · Since at least Feb 1, 2022 |
| Dawn Castro | Senior Vice President – Chief Revenue Cycle Officer · Since at least Nov 4, 2026 |
| Eric Evans | Chief Executive Officer · Since at least Oct 26, 2026 |
| Harrison R Bane | National Group President · Since at least Sep 30, 2022 |
| Jackie Wright | Senior Vice President – Chief Procurement Officer · Since at least Nov 4, 2026 |
| Jane Vanderbilt | Senior Vice President – Business Operations · Since at least Nov 4, 2026 |
| Jennifer Baldock | Executive Vice President – Chief Administrative and Development Officer · Since at least Dec 8, 2025 |
| Jeremy Clark | North Division, President · Since at least Nov 4, 2026 |
| John A Deane | Director · Since at least May 29, 2019 |
| Jon Fredrickson | Senior Vice President – Chief Information Officer · Since at least Nov 4, 2026 |
| Justin Oppenheimer | Executive Vice President – Chief Operating Officer · Since at least Jan 1, 2026 |
| Kelly T. Whelan | Senior Vice President – General Counsel · Since at least Nov 4, 2026 |
| Kristi Jensen | Market CEO (Northeast) and Enterprise Operational Excellence · Since at least Nov 4, 2026 |
| Laura L Brocklehurst | Chief Human Resources Officer · Jan 1, 2021 – Nov 9, 2022 · Past |
| Marissa Brittenham | Executive Vice President – Chief Strategy Officer · Since at least Jan 10, 2022 |
| Mike Maley | West Division, President · Since at least Nov 4, 2026 |
| Noah Clevenger | Market CEO (Illinois) and Enterprise Preferred Vascular · Since at least Nov 4, 2026 |
| Patrick Brown | Senior Vice President – Market Growth and Business Development · Since at least Nov 4, 2026 |
| Roxanne Womack | Senior Vice President – Chief Compliance Officer · Since at least Nov 4, 2026 |
| Shannon Yarrow | Senior Vice President – Managed Care · Since at least Nov 4, 2026 |
| Sid Soonasra | Senior Vice President - Physician Practice and Anesthesia Operations · Since at least Nov 4, 2026 |
| Spencer Clark | Senior Vice President – General Counsel · Since at least Nov 4, 2026 |
| Steven Cornelison | Senior Vice President – Treasurer · Since at least Nov 4, 2026 |
| Tamala Norris-McJunkins | Senior Vice President – Enterprise Chief Clinical Officer · Since at least Nov 4, 2026 |
| Trent Webb | South Division, President · Since at least Nov 4, 2026 |
| William Trenton Webb | American Group President · Since at least Sep 1, 2024 |
Log in to ask 6ix AI your own questions about Surgery Partners, Inc.